Intellectual Disability
168
29
37
94
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
14 trials with published results (8%)
Research Maturity
94 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
3 terminated out of 168 trials
96.9%
+10.3% vs benchmark
3%
5 trials in Phase 3/4
15%
14 of 94 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 94 completed trials
Clinical Trials (168)
Characterization of Nociception Phenotype in Individuals With Intellectual Disability
Virtual Reality Task-Oriented Physical Activity in Adults With Mental Disabilities
Escalating Doses of Memantine in Down Syndrome (MEDS-123)
Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability
Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT
Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation
We Walk Plus Study for Older Adults With Intellectual Disabilities
Testing an Evidence-Based Supported Employment Model in Autistic Young Adults
Effects of Exercise Snacks on Physical Health and Cognitive Function in Individuals With Intellectual Disabilities
FAB Programme for Parents of Children With NDD
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental Disorders
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Evaluation of the Effect of Digital-based Games on the Visual and Cognitive Performance of Young Children With Intellectual Disabilities
Handgrip Strength, Trunk Muscle Endurance, and Functional Mobility in Adolescents With Mild Intellectual Disability
Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation
Online Learning Module to Advance Research Related to People With Disabilities
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Rett Syndrome Registry